Screener
Ironwood Pharmaceuticals IRWD Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed November 10, 2025.
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001104659-25-108795
| Line item | Nine Months Ended / September 30, 2025 | Nine Months Ended / September 30, 2024 |
|---|---|---|
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 1,421 | 1,526 |
| Loss on disposal of property and equipment | 92 | 75 |
| Share-based compensation expense | 13,427 | 25,284 |
| Non-cash interest expense | 1,250 | 1,489 |
| Non-cash lease expense | 1,253 | 1,156 |
| Deferred income taxes | 42,547 | 26,986 |
| Changes in assets and liabilities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's compensation and benefits?
- Ironwood Pharmaceuticals (IRWD) reported compensation and benefits of $3.61M in Q3 2025.
- How has Ironwood Pharmaceuticals's compensation and benefits changed year-over-year?
- Ironwood Pharmaceuticals's compensation and benefits decreased by 56.6% year-over-year, from $8.33M to $3.61M.
- What is the long-term trend for Ironwood Pharmaceuticals's compensation and benefits?
- Over 2 years (2021 to 2024), Ironwood Pharmaceuticals's compensation and benefits has grown at a 15.7% compound annual growth rate (CAGR), from $22.28M to $29.85M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Ironwood Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude